Improved understanding of the interconnection between aging and mitochondrial Ca2+ and ROS homeostasis, identification of Fus1 transcriptional targets specifically involved in aging, and new drugs that modulate particular Fus1-dependent aspects of Ca2+ signaling may ultimately lead to the development of novel strategies to prevent and/or treat age-related pathologies. This evidence concerns the gene TUSC2 and age.